Site Search
Professionals 197 results
Capabilities 32 results
Industry
Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations.
Practice Area
With an international geographic reach, Winston & Strawn’s integrated tax practice addresses virtually all areas of tax law. Our group of 40 tax attorneys is well-versed in representing some of the largest public and privately-held corporations, exempt organizations, and large estates.
Industry
Cryptocurrencies, Digital Assets & Blockchain Technology
As interest in digital assets continues to rise, novel and complex legal issues emerge continually. Winston’s cross-border interdisciplinary team provides comprehensive regulatory, litigation, and transactional services on the array of issues confronting the digital assets industry. Our dedicated team features pioneering attorneys in the sector, leading litigators, former senior regulators, and in-house counsel.
Experience 213 results
Experience
|December 3, 2025
US Tiger Securities Announced IPO
Winston & Strawn LLP is serving as U.S. securities counsel to US Tiger Securities, Inc., a full-service broker/dealer, in connection with the $10,000,000 initial public offering of SMJ International Holdings Inc., a Singapore-based premium flooring specialist. The Company priced 2,500,000 Class A ordinary shares at US$4.00 per share. The Class A ordinary shares are expected to begin trading on the NYSE American under the ticker symbol “SMJF” on December 4, 2025.
Experience
|October 27, 2025
Winston Advised GenNx360 Capital Partners in its sale of Aero 3, Inc.
A Winston team led by Justin Levy and Eric Kaufman represented GenNx360 Capital Partners, a New York-based private equity firm investing in industrial and service companies, in connection with the sale of Aero 3, Inc. to VSE Corporation (NASDAQ: VSEC), a leading provider of aviation aftermarket distribution and repair services. Headquartered in Manchester, New Hampshire, Aero 3 is a diversified global Maintenance, Repair and Overhaul (MRO) service provider and distributor supporting the commercial wheel and brake aftermarket. This transaction builds on GenNx360’s successful buy-and-build strategy.
Experience
|October 24, 2025
$400 Million GATX Corporation Senior Notes Offering
Represented joint book-running managers BofA Securities, Inc., Citigroup Global Markets Inc., and Morgan Stanley & Co. LLC, as underwriters' counsel, in connection with the registered public offering by GATX Corporation of $200 million of its 5.500% Senior Notes due 2035 and $200 million of its 6.050% Senior Notes due 2054.
Insights & News 1,361 results
In the Media
|November 14, 2025
|1 Min Read
Daniel Stabile Discusses Pressing Issues for Incoming CFTC Chair with Law.com
Winston & Strawn partner Daniel Stabile spoke with Law.com to discuss prediction markets, collaboration with the SEC, and other issues that the incoming Commodity Futures Trading Commission (CFTC) chair will face in the new role following President Trump’s nomination of Michael Selig to the position.
Competition Corner
|November 11, 2025
|6 Min Read
Google’s $2.3 Million Mistake: How a Bench-Trial Play Became a Preclusion Problem
While Google’s strategy eliminated the short-term risk of a potentially volatile jury, it exposed the company to a devastating, long-term issue preclusion risk. This article explains why Google’s bench-trial gamble backfired, and what antitrust defendants can learn from it.
Recognitions
|November 10, 2025
|1 Min Read
Winston Shortlisted for Financial Times 2025 Innovative Lawyers North America Awards
Winston & Strawn has been shortlisted for the Financial Times 2025 Innovative Lawyers North America Awards in the Unlocking Capital category, recognizing the firm’s work advising Groupon, Inc. in its US$80M fully backstopped rights offering for shares of the Company’s common stock.
Other Results 14 results
Site Content
Site Content
Location
Opened in 2017, Winston & Strawn’s Dallas office is located in the cultural and economic epicenter of DFW, the fourth largest metropolitan area in the U.S. and the fastest growing over the last year. Our Dallas attorneys litigate both high-stakes civil and criminal matters, including major state and federal trials and appeals nationwide, and represent clients in complex transactional matters. Under the leadership of Bryan L. Goolsby, our office—made up of nearly 100 lawyers—continues to expand, attracting some of the country’s top legal talent to meet the increased needs of the many technology, investment, and healthcare companies that are increasingly making Dallas their home.